ATE225171T1 - Aminosäurederivate zur behandlung von schlaganfall - Google Patents

Aminosäurederivate zur behandlung von schlaganfall

Info

Publication number
ATE225171T1
ATE225171T1 AT98934465T AT98934465T ATE225171T1 AT E225171 T1 ATE225171 T1 AT E225171T1 AT 98934465 T AT98934465 T AT 98934465T AT 98934465 T AT98934465 T AT 98934465T AT E225171 T1 ATE225171 T1 AT E225171T1
Authority
AT
Austria
Prior art keywords
stroke
treatment
amino acid
acid derivatives
treating
Prior art date
Application number
AT98934465T
Other languages
English (en)
Inventor
Robert H Harris
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Application granted granted Critical
Publication of ATE225171T1 publication Critical patent/ATE225171T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98934465T 1997-07-15 1998-07-15 Aminosäurederivate zur behandlung von schlaganfall ATE225171T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5268497P 1997-07-15 1997-07-15
PCT/US1998/014449 WO1999003460A1 (en) 1997-07-15 1998-07-15 Amino acid derivatives useful to treat stroke

Publications (1)

Publication Number Publication Date
ATE225171T1 true ATE225171T1 (de) 2002-10-15

Family

ID=21979231

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98934465T ATE225171T1 (de) 1997-07-15 1998-07-15 Aminosäurederivate zur behandlung von schlaganfall

Country Status (10)

Country Link
US (1) US6133261A (de)
EP (1) EP0996435B1 (de)
JP (1) JP4213339B2 (de)
AT (1) ATE225171T1 (de)
AU (1) AU744899B2 (de)
CA (1) CA2296560C (de)
DE (1) DE69808475T2 (de)
DK (1) DK0996435T3 (de)
ES (1) ES2184300T3 (de)
WO (1) WO1999003460A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1486205B1 (de) 2000-08-25 2007-10-17 Research Corporation Technologies, Inc Verwendung von antikonvulsiven Aminosäure zur Behandlung von Migräne
WO2005053667A1 (en) * 2003-12-02 2005-06-16 Schwarz Pharma Ag Novel use of peptide compounds for treating central neuropathic pain
AU2005232395B2 (en) * 2004-04-16 2010-09-09 Schwarz Pharma Ag Use of peptidic compounds for the prophylaxis and treatment of chronic headache
AU2005245962A1 (en) * 2004-05-21 2005-12-01 Mpex Pharmaceuticals, Inc. Bacterial efflux pump inhibitors and methods of treating bacterial infections
US7879795B2 (en) 2004-05-21 2011-02-01 Mpex Pharmaceuticals, Inc. Enhancement of tigecycline potency using efflux pump inhibitors
US20060252749A1 (en) * 2005-01-28 2006-11-09 Srz Properties, Inc. Lacosamide for add-on therapy of psychosis
EP1754476A1 (de) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamid (SPM 927) zur Behandlung von Myalgien, z.B. Fibromyalgie
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
EP2462990B2 (de) 2006-06-15 2018-04-18 UCB Pharma GmbH Pharmazeutische Zubereitung, enthaltend Lacosamide und Levetiracetam, mit synergistischer antikonvulsiver Wirkung
US8178490B2 (en) * 2007-05-11 2012-05-15 Rempex Pharmaceuticals, Inc. Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
EP2645997B1 (de) 2010-12-02 2022-08-10 UCB Pharma GmbH Einmal-täglich-formulierung von lacosamid
EP2468261A1 (de) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulierung von Lacosamid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654301A (en) * 1985-02-15 1997-08-05 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
US5331007A (en) * 1987-02-06 1994-07-19 Fisons Corporation Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties

Also Published As

Publication number Publication date
DE69808475D1 (de) 2002-11-07
US6133261A (en) 2000-10-17
AU8397898A (en) 1999-02-10
AU744899B2 (en) 2002-03-07
EP0996435A1 (de) 2000-05-03
DK0996435T3 (da) 2003-01-27
CA2296560C (en) 2006-12-19
DE69808475T2 (de) 2003-01-30
ES2184300T3 (es) 2003-04-01
CA2296560A1 (en) 1999-01-28
JP2002527350A (ja) 2002-08-27
WO1999003460A1 (en) 1999-01-28
EP0996435B1 (de) 2002-10-02
JP4213339B2 (ja) 2009-01-21

Similar Documents

Publication Publication Date Title
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
ATE301995T1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
DE69909818D1 (de) Pyrazolopyimidinon-derivate zur behandlung von impotenz
EE200000318A (et) Uudsed ühendid
UA66865C2 (uk) Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти)
BG100930A (bg) Фармацевтични състави и лекарствени средства за профилактика и лечение на ендотелиални нарушения
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69831409D1 (de) Chalcon-derivate mit antiproliferativer aktivität
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
DE69818823D1 (de) Dipohosphonsäuresalze für die behandlung von osteoporose
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
BR9811348A (pt) Compostos derivados de indol, processo para preparação dos mesmos, e, composições farmacêuticas.
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
DE69736180D1 (de) Behandlung von manischen erkrankungen
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
DE60010934D1 (de) Medikamente geeignet zur Behandlung von proliferativen Erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0996435

Country of ref document: EP